[SYRE] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Jun-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- -14.36%
YoY- -18.86%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 688 625 13,696 0 0 2,378 1,479 -11.97%
PBT -217,074 -22,314 -6,738 -21,418 -18,019 -9,414 -6,632 78.80%
Tax 7 9 92 0 0 0 0 -
NP -217,081 -22,323 -6,830 -21,418 -18,019 -9,414 -6,632 78.80%
Tax Rate - - - - - - - -
Total Cost 217,769 22,948 20,526 21,418 18,019 11,792 8,111 72.99%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -31,552.47 -3,571.68 -49.87 0.00 0.00 -395.88 -448.41 103.11%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -56.79 -6.79 -2.60 -10.11 -13.72 -11.43 -11.75 30.01%
EPS Diluted -56.79 -6.79 -2.60 -10.11 -13.72 -11.43 -11.75 30.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.